Trials / Completed
CompletedNCT02485028
Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg
An Open Label, Randomized, Single-dose Crossover Study to Evaluate the Pharmacokinetic Interaction of Dapoxetine 30mg and Mirodenafil 50mg in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- SK Chemicals Co., Ltd. · Industry
- Sex
- Male
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Healthy male volunteers were administered alone and in combination with dapoxetine 30mg mirodenafil 50mg for three times, respectively and the pharmacokinetic interaction was compared between the two drugs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dapoxetine 30mg tablet | |
| DRUG | Mirodenafil 50mg tablet |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2015-06-30
- Last updated
- 2015-06-30
Source: ClinicalTrials.gov record NCT02485028. Inclusion in this directory is not an endorsement.